Disinfection Strategies for Carbapenem-Resistant Klebsiella pneumoniae in a Healthcare Facility

Disinfectant resistance is evolving into a serious problem due to the long-term and extensive use of disinfectants, which brings great challenges to hospital infection control. As a notorious multidrug-resistant bacterium, carbapenem-resistant Klebsiella pneumoniae (CRKP) is one of the most common and difficult pathogens of nosocomial infection. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) tests of seven kinds of disinfectants (0.1% benzalkonium bromide, 4% aqueous chlorhexidine, 75% alcohol, entoiodine II, 2% glutaraldehyde, 2000 mg/L chlorine-containing disinfectants, and 3% hydrogen peroxide) were detected by the broth dilution method. Three efflux pump genes (oqxA, oqxB, and qacE∆1-sul1) were detected by PCR. The mean MIC value of aqueous chlorhexidine from the intensive care unit (ICU) (0.0034%) was significantly higher than that from non-ICUs (0.0019%) (p < 0.05). The positive rates of three efflux pump genes oqxA, oqxB and qacE∆1-sul1 were 60.9% (39/64), 17.2% (11/64) and 71.9% (46/64) in the detected CRKP isolates, respectively. This study discovered that CRKP strains demonstrated extensive resistance to clinical disinfectants and suggest that it is necessary to perform corresponding increases in the concentration of aqueous chlorhexidine and chlorine-containing disinfectants on the basis of current standards in the healthcare industry.

[1]  B. Bakhshi,et al.  Phenotypic and genotypic changes of Staphylococcus aureus in the presence of the inappropriate concentration of chlorhexidine gluconate , 2022, BMC microbiology.

[2]  R. Nakashima,et al.  Function and Inhibitory Mechanisms of Multidrug Efflux Pumps , 2021, Frontiers in Microbiology.

[3]  V. Morrison,et al.  Antimicrobial stewardship and infection prevention interventions targeting healthcare-associated Clostridioides difficile and carbapenem-resistant Klebsiella pneumoniae infections: a scoping review , 2021, BMJ Open.

[4]  G. Igrejas,et al.  Multidrug-resistant Klebsiella pneumoniae harboring extended spectrum β-lactamase encoding genes isolated from human septicemias , 2021, PloS one.

[5]  J. Knobloch,et al.  Practical recommendations for routine cleaning and disinfection procedures in healthcare institutions: a narrative review. , 2021, The Journal of hospital infection.

[6]  J. Timsit,et al.  The Impact of Carbapenem Resistance on Mortality in Patients With Klebsiella Pneumoniae Bloodstream Infection: An Individual Patient Data Meta-Analysis of 1952 Patients , 2021, Infectious Diseases and Therapy.

[7]  M. J. Pons,et al.  Tolerance to disinfectants (chlorhexidine and isopropanol) and its association with antibiotic resistance in clinically-related Klebsiella pneumoniae isolates , 2021, Pathogens and global health.

[8]  S. Fanning,et al.  Klebsiella pneumoniae: Prevalence, Reservoirs, Antimicrobial Resistance, Pathogenicity, and Infection: A Hitherto Unrecognized Zoonotic Bacterium. , 2020, Foodborne pathogens and disease.

[9]  Ya-Min Tsai,et al.  Combination of modified carbapenem inactivation method (mCIM) and EDTA-CIM (eCIM) for phenotypic detection of carbapenemase-producing Enterobacteriaceae , 2020, BMC microbiology.

[10]  R. Nabizadeh,et al.  Comparative efficacy of hospital disinfectants against nosocomial infection pathogens , 2020, Antimicrobial Resistance & Infection Control.

[11]  L. Talbot,et al.  Preoperative Chlorhexidine Gluconate Bathing on a Military Medical-Surgical Unit. , 2020, Military medicine.

[12]  Wei Zhu,et al.  Risk factors for carbapenem-resistant Klebsiella pneumoniae infection relative to two types of control patients: a systematic review and meta-analysis , 2020, Antimicrobial Resistance & Infection Control.

[13]  Y. Huang,et al.  Determining the susceptibility of carbapenem resistant Klebsiella pneumoniae and Escherichia coli strains against common disinfectants at a tertiary hospital in China , 2020, BMC Infectious Diseases.

[14]  Hongwei Zhou,et al.  Prevalence, risk factors and molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae in patients from Zhejiang, China, 2008–2018 , 2020, Emerging microbes & infections.

[15]  Jing Guo,et al.  Molecular epidemiology and decreased susceptibility to disinfectants in carbapenem-resistant Acinetobacter baumannii isolated from intensive care unit patients in central China. , 2019, Journal of infection and public health.

[16]  M. Owens,et al.  Does oral care with chlorhexidine reduce ventilator-associated pneumonia in mechanically ventilated adults? , 2019, British journal of nursing.

[17]  Thi Thanh Nga Tran,et al.  Effect of carbapenem resistance on outcomes of bloodstream infection caused by Enterobacteriaceae in low-income and middle-income countries (PANORAMA): a multinational prospective cohort study. , 2019, The Lancet. Infectious diseases.

[18]  J. Lutgring,et al.  Carbapenem-resistant Enterobacteriaceae: An emerging bacterial threat. , 2019, Seminars in diagnostic pathology.

[19]  R. Bonomo,et al.  Carbapenem-resistant Enterobacteriaceae: global action required. , 2019, The Lancet. Infectious diseases.

[20]  Guyue Cheng,et al.  The nature and epidemiology of OqxAB, a multidrug efflux pump , 2019, Antimicrobial Resistance & Infection Control.

[21]  G. Kampf.  Biocidal Agents Used for Disinfection Can Enhance Antibiotic Resistance in Gram-Negative Species , 2018, Antibiotics.

[22]  M. Licker,et al.  Multidrug-Resistant Gram-Negative Bacilli: A Retrospective Study of Trends in a Tertiary Healthcare Unit , 2018, Medicina.

[23]  U. Truyen,et al.  Development and evaluation of a broth macrodilution method to determine the biocide susceptibility of bacteria. , 2018, Veterinary microbiology.

[24]  K. Konstantinidis,et al.  Widely Used Benzalkonium Chloride Disinfectants Can Promote Antibiotic Resistance , 2018, Applied and Environmental Microbiology.

[25]  J. Maillard.  Resistance of Bacteria to Biocides , 2018, Microbiology spectrum.

[26]  J. Lucet,et al.  Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: guidance from the European Centre for Disease Prevention and Control , 2017, Antimicrobial Resistance & Infection Control.

[27]  T. Palmore,et al.  Preventing Transmission of Multidrug-Resistant Pathogens in the Intensive Care Unit. , 2017, Infectious disease clinics of North America.

[28]  G. Carter,et al.  Current and Emerging Topical Antibacterials and Antiseptics: Agents, Action, and Resistance Patterns , 2017, Clinical Microbiology Reviews.

[29]  H. Worthington,et al.  Chlorhexidine mouthrinse as an adjunctive treatment for gingival health. , 2017, The Cochrane database of systematic reviews.

[30]  Xiaoling Ma,et al.  Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae , 2017, Annals of Clinical Microbiology and Antimicrobials.

[31]  A. Gálvez,et al.  Virulence factors and antimicrobial resistance in Escherichia coli strains isolated from hen egg shells. , 2016, International journal of food microbiology.

[32]  M. Ateş,et al.  Antimicrobial activity of different disinfectants against cariogenic microorganisms. , 2016, Brazilian oral research.

[33]  G. Dantas,et al.  The rapid spread of carbapenem-resistant Enterobacteriaceae. , 2016, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[34]  M. L. Cristina,et al.  Epidemiology and biomolecular characterization of carbapenem-resistant klebsiella pneumoniae in an Italian hospital , 2016, Journal of preventive medicine and hygiene.

[35]  P. Amiri,et al.  Correlation Between qacE and qacE∆1 Efflux Pump Genes, Antibiotic and Disinfectant Resistant Among Clinical Isolates of E.coli. , 2016, Recent patents on anti-infective drug discovery.

[36]  R. Humphries,et al.  Clinical laboratory detection of carbapenem-resistant and carbapenemase-producing Enterobacteriaceae , 2016, Expert review of anti-infective therapy.

[37]  M. Bhatia,et al.  Reduced susceptibility of carbapenem-resistant Klebsiella pneumoniae to biocides: An emerging threat , 2016, Indian journal of medical microbiology.

[38]  Basappa B. Kaliwal,et al.  Resistance in Bacteria , 2016 .

[39]  F. Robin,et al.  Correlation between antimicrobial resistance and virulence in Klebsiella pneumoniae , 2016, European Journal of Clinical Microbiology & Infectious Diseases.

[40]  S. Beatson,et al.  Stepwise evolution of pandrug-resistance in Klebsiella pneumoniae , 2015, Scientific Reports.

[41]  P. Nordmann,et al.  Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance , 2015, Antimicrobial Agents and Chemotherapy.

[42]  Wei Guo,et al.  Determining the resistance of carbapenem-resistant Klebsiella pneumoniae to common disinfectants and elucidating the underlying resistance mechanisms , 2015, Pathogens and global health.

[43]  Xin Hu,et al.  First Emergence of acrAB and oqxAB Mediated Tigecycline Resistance in Clinical Isolates of Klebsiella pneumoniae Pre-Dating the Use of Tigecycline in a Chinese Hospital , 2014, PloS one.

[44]  K. Kusza,et al.  The prevalence of infections and colonisation with Klebsiella pneumoniae strains isolated in ICU patients. , 2014, Anaesthesiology intensive therapy.

[45]  J. Maillard,et al.  Does microbicide use in consumer products promote antimicrobial resistance? A critical review and recommendations for a cohesive approach to risk assessment. , 2013, Microbial drug resistance.

[46]  Jien-Wei Liu,et al.  Antibiotic Consumption and Healthcare-Associated Infections Caused by Multidrug-Resistant Gram-Negative Bacilli at a Large Medical Center in Taiwan from 2002 to 2009: Implicating the Importance of Antibiotic Stewardship , 2013, PloS one.

[47]  C. Edmiston,et al.  Reducing the risk of surgical site infections: does chlorhexidine gluconate provide a risk reduction benefit? , 2013, American journal of infection control.

[48]  S. Marathe,et al.  Biocides – resistance, cross-resistance mechanisms and assessment , 2013, Expert opinion on investigational drugs.

[49]  P. Nordmann,et al.  Carbapenem resistance in Enterobacteriaceae: here is the storm! , 2012, Trends in molecular medicine.

[50]  Thierry Naas,et al.  Global Spread of Carbapenemase-producing Enterobacteriaceae , 2011, Emerging infectious diseases.

[51]  G. Jacoby,et al.  oqxAB Encoding a Multidrug Efflux Pump in Human Clinical Isolates of Enterobacteriaceae , 2009, Antimicrobial Agents and Chemotherapy.

[52]  K. Poole.  Efflux pumps as antimicrobial resistance mechanisms , 2007, Annals of medicine.

[53]  L. Piddock.  Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria , 2006, Clinical Microbiology Reviews.

[54]  X. Xu,et al.  [Investigation of acquired drug-resistant genes and strains relationship in Pseudomonas aeruginosa isolated from burn patients]. , 2018, Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns.

[55]  J. Maillard,et al.  Efflux pump induction by quaternary ammonium compounds and fluoroquinolone resistance in bacteria. , 2016, Future microbiology.